These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rationale for treating angina pectoris in patients with heart failure. Heikkilä J Acta Med Scand Suppl; 1985; 694():166-77. PubMed ID: 2860772 [No Abstract] [Full Text] [Related]
23. Stable angina: maximal medical therapy is not the same as optimal medical therapy. Jackson G Int J Clin Pract; 2000; 54(6):351. PubMed ID: 11092105 [No Abstract] [Full Text] [Related]
24. Drugs and the heart. III. Calcium antagonists. Opie LH Lancet; 1980 Apr; 1(8172):806-10. PubMed ID: 6102688 [No Abstract] [Full Text] [Related]
25. The treacherous waters of unstable angina pectoris. Burden LL; Atwell K Nursing; 1983 Dec; 13(12):50-6. PubMed ID: 6139777 [No Abstract] [Full Text] [Related]
26. Betablockers in combination with other antihypertensives. Manjuran RJ Indian Heart J; 2010; 62(2):146-7. PubMed ID: 21180307 [TBL] [Abstract][Full Text] [Related]
27. Practical guidelines for treatment with beta-blockers and nitrates in patients with acute myocardial infarction. Simoons ML; Serruys PW; Fioretti P; van den Brand M; Hugenholtz PG Eur Heart J; 1983 Jul; 4 Suppl D():129-35. PubMed ID: 6137371 [TBL] [Abstract][Full Text] [Related]
28. Rational medical therapy for stable angina pectoris. Hoekenga D; Abrams J Am J Med; 1984 Feb; 76(2):309-14. PubMed ID: 6141729 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of calcium-channel-blocking agents. Braunwald E N Engl J Med; 1982 Dec; 307(26):1618-27. PubMed ID: 6292718 [No Abstract] [Full Text] [Related]
31. [Clinical use of beta adrenergic inhibiting agents in cardiovascular therapeutics]. Scebat L Therapeutique; 1968 Nov; 44(9):560-4. PubMed ID: 4396094 [No Abstract] [Full Text] [Related]
32. [Current treatment of cardiovascular diseases with special reference to long-term therapy]. Sundermann A Z Arztl Fortbild (Jena); 1967 Jun; 61(12):614-8. PubMed ID: 4969503 [No Abstract] [Full Text] [Related]
33. [Beta-blockers in effort angina]. Witchitz S; Kolsky H; Moisson P; Philippe B Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():87-95. PubMed ID: 6134513 [No Abstract] [Full Text] [Related]
34. [Diagnosis and drug therapy in the postinfarct phase]. Kronik G Wien Med Wochenschr; 1984 Dec; 134(23-24):557-63. PubMed ID: 6152090 [TBL] [Abstract][Full Text] [Related]
35. Use of beta-blockers during and after myocardial infarction. Aronow WS Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular drugs and exercise. Lowenthal DT; Kendrick ZV; Chase R; Paran E; Perlmutter G Exerc Sport Sci Rev; 1987; 15():67-94. PubMed ID: 2885201 [No Abstract] [Full Text] [Related]
37. [Results of the conservative treatment of patients with unstable stenocardia]. Ioseliani DG; Mshvidobadze TA; Vasilidze TV; Movelidze TA Kardiologiia; 1986 May; 26(5):40-5. PubMed ID: 2874256 [TBL] [Abstract][Full Text] [Related]
38. [Therapy of angina pectoris]. Sterz H Wien Med Wochenschr; 1984 Dec; 134(23-24):534-9. PubMed ID: 6152089 [TBL] [Abstract][Full Text] [Related]
39. Which beta-blocker? Med Lett Drugs Ther; 2001 Feb; 43(1097):9-11. PubMed ID: 11177223 [No Abstract] [Full Text] [Related]
40. Selection of optimal drug therapy for the patient with angina pectoris. Shub C; Vlietstra RE; McGoon MD Mayo Clin Proc; 1985 Aug; 60(8):539-48. PubMed ID: 2862309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]